C3 ( CTHR ) Diamond in the rough? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : C3 ( CTHR ) Diamond in the rough?

CTHR 0.400

+263.6%

Oct 31 12:16 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: dennis michael patterson who wrote (4)	11/16/1997 3:34:00 AM
From: Leslie S. Feinberg	Read Replies (1) of 226

Dennis; C3 has the potential to take the material Cree uses to make it's commodity SiC products transformed into an extremely appealing, proprietarily manufactured gem unlike anything ever manufactured before and turn it into a sexy, very profitable business. 93% of professional jewelers can't tell C3 gems from high quality diamonds. By contrast any dummy can see that currently available diamond substitutes aren't even close. Cree is about 4 years old as a publicly traded stock. When C3 reaches this milestone it will long since have eclipsed Cree's performance IMHO. Les

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next